Fundraising FoxAquinnah Pharmaceuticals
Cambridge, US · 2 known investors
Find your way into Aquinnah Pharmaceuticals
Sign up to see every warm intro you have to Aquinnah Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aquinnah Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Aquinnah Pharmaceuticals develops oral small-molecule therapeutics targeting pathologic biomolecular condensates, such as stress granules formed by RNA-binding proteins, to slow neurodegenerative diseases including ALS and Alzheimer's disease. The company focuses on drug discovery for neurological disorders with high unmet medical need.
Founders & leadership
Investors · 2
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: a partner's Signal profile · Not right? Tell us
In the news
Frequently asked questions
- What does Aquinnah Pharmaceuticals do?
- Aquinnah Pharmaceuticals develops oral small-molecule therapeutics targeting pathologic biomolecular condensates, such as stress granules formed by RNA-binding proteins, to slow neurodegenerative diseases including ALS and Alzheimer's disease. The company focuses on drug discovery for neurological disorders with high unmet medical need.
- Who founded Aquinnah Pharmaceuticals?
- Aquinnah Pharmaceuticals was founded by Benjamin Wolozin.
- Who are Aquinnah Pharmaceuticals's investors?
- Aquinnah Pharmaceuticals's investors include Pfizer Venture Investments, AbbVie.
- Where is Aquinnah Pharmaceuticals headquartered?
- Aquinnah Pharmaceuticals is headquartered in Cambridge, US.